Radiomer

Radiomer Novel radiopharmaceutical radioligand therapy platform that leverages raptamersᵀᴹ (peptide oligonucleotide hybrids) as a targeting moiety vector. Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related it management systems.

Radiomer Radiomer therapeutics | 295 followers on linkedin. novel radiopharmaceutical radioligand therapy platform that leverages raptamersᵀᴹ (peptide oligonucleotide hybrids) as a targeting moiety. Fannin, the parent company of radiomer therapeutics, was particularly interested in creating targeted drugs for cancer, and was searching for a platform that could do it rapidly and cost effectively. Компания radiomer предлагает услуги по разработе электронных устройств под ключ по заданию заказчика, а также, услуги по созданию программного обеспечения для компьютеров для управления. Radiomer therapeutics is a company that develops a radioligand therapy platform. it specializes in radiomers and targeted radiopharmaceuticals for theranostic applications.

Pipeline Radiomer Компания radiomer предлагает услуги по разработе электронных устройств под ключ по заданию заказчика, а также, услуги по созданию программного обеспечения для компьютеров для управления. Radiomer therapeutics is a company that develops a radioligand therapy platform. it specializes in radiomers and targeted radiopharmaceuticals for theranostic applications. Information on valuation, funding, cap tables, investors, and executives for radiomer therapeutics. use the pitchbook platform to explore the full profile. Radiomer therapeutics is a biopharmaceutical company focused on developing targeted radiopharmaceuticals and radioligand therapies for theranostic applications. the company uses a proprietary raptamer platform to create novel targeting agents that enhance binding affinity. Radiomer therapeutics develops radiomers, targeted radiopharmaceuticals radiolig and therapies. Radiomer therapeutics, inc. is developing radiomers, targeted radiopharmaceuticals radioligand therapies, for theranostic applications using its novel raptamer platform.

Contact Us Radiomer Information on valuation, funding, cap tables, investors, and executives for radiomer therapeutics. use the pitchbook platform to explore the full profile. Radiomer therapeutics is a biopharmaceutical company focused on developing targeted radiopharmaceuticals and radioligand therapies for theranostic applications. the company uses a proprietary raptamer platform to create novel targeting agents that enhance binding affinity. Radiomer therapeutics develops radiomers, targeted radiopharmaceuticals radiolig and therapies. Radiomer therapeutics, inc. is developing radiomers, targeted radiopharmaceuticals radioligand therapies, for theranostic applications using its novel raptamer platform.

Team Radiomer Radiomer therapeutics develops radiomers, targeted radiopharmaceuticals radiolig and therapies. Radiomer therapeutics, inc. is developing radiomers, targeted radiopharmaceuticals radioligand therapies, for theranostic applications using its novel raptamer platform.